SLC2A1 and cancer: The metabolic shift in KRAS-mutant cancer cells relies on a high absorption of glucose mediated by abundant glucose transporters (GLUT) where GLUT1 is considered as a key supplier of glucose in cancer cells promoting an aerobic glycolysis in tumorigenesis (Figure 5) [84].